slide deck (pdf) - CME Outfitters
slide deck (pdf) - CME Outfitters slide deck (pdf) - CME Outfitters
Rosenberg MT, et al. Publication Pending The Next STEP: Step 1
STEP 1: Informed Surveillance If the patient has symptoms but no bother and no complications Patients who opt for this option may benefit from: ! Lifestyle changes (exercise, weight management) ! Limitations of fluids ! Bladder training focused on timed and complete voiding ! Medication modification ! Although LUTS secondary to BPH is not often a lifethreatening condition, the impact of LUTS/BPH on quality of life (QoL) can be significant and should not be underestimated Burgio KL, et al. Int J Clin Pract. 2013;67(6):495-504.PMID: 23679903
- Page 1 and 2: Gaining Ground in Men’s Genitouri
- Page 3 and 4: Accreditation This program has been
- Page 5 and 6: Learning Objectives ! Explain the s
- Page 7 and 8: Matt T. Rosenberg, MD Disclosures S
- Page 9 and 10: Disclosures ! Faculty of this CE ac
- Page 11 and 12: Get Social with Us CMEOutfitters.co
- Page 13 and 14: Georgia Association of Physician As
- Page 15 and 16: Matt T. Rosenberg, MD Disclosures S
- Page 17 and 18: In what percentage of your patients
- Page 19 and 20: Function of the Prostate Normal Fun
- Page 21 and 22: Benign Prostatic Hyperplasia ! A co
- Page 23 and 24: Predominant Symptoms ! The enlarged
- Page 25 and 26: Definition of OAB International Con
- Page 27 and 28: How to differentiate the etiology o
- Page 29 and 30: Common Comorbidities in BPH-LUTS Co
- Page 31 and 32: Audience Response Question Fact: ED
- Page 33 and 34: BPH-LUTS and ED Common Pathophysiol
- Page 35 and 36: What to Keep in Mind in the Evaluat
- Page 37 and 38: The Evaluation of LUTS: History, Ph
- Page 39 and 40: Medications Can Cause or Exacerbate
- Page 41 and 42: Laboratory Tests ! Urinalysis ! Inf
- Page 43 and 44: Audience Response Question The most
- Page 45 and 46: The Purpose of the Voiding Diary !
- Page 47: Rosenberg MT, et al. Publication Pe
- Page 51 and 52: Clinical Management Step2a: Alpha B
- Page 53 and 54: Clinical Management Step2b: Phospho
- Page 55 and 56: Rosenberg MT, et al. Publication Pe
- Page 57 and 58: Antimuscarinics - Immediate Release
- Page 59 and 60: ! Dry Mouth ! Constipation ! Headac
- Page 61 and 62: Beta 3 Agonists Drug Mirabegron Dos
- Page 63 and 64: Clinical Management Step3b: Adding
- Page 65 and 66: 5 Alpha Reductase Inhibitors (5ARI)
- Page 67 and 68: Rosenberg MT, et al. Publication Pe
- Page 69 and 70: Clinical Connections: Summary ! Tre
STEP 1: Informed Surveillance<br />
If the patient has symptoms but no bother<br />
and no complications<br />
Patients who opt for this option may benefit from:<br />
! Lifestyle changes (exercise, weight management)<br />
! Limitations of fluids<br />
! Bladder training focused on timed and complete voiding<br />
! Medication modification<br />
! Although LUTS secondary to BPH is not often a lifethreatening<br />
condition, the impact of LUTS/BPH on<br />
quality of life (QoL) can be significant and should not be<br />
underestimated<br />
Burgio KL, et al. Int J Clin Pract. 2013;67(6):495-504.PMID: 23679903
Change language